The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
A humanized antibody that binds to the interleukin 2 receptor.
Open accessAbstract
The anti-Tac monoclonal antibody is known to bind to the p55 chain of the human interleukin 2 receptor and to inhibit proliferation of T cells by blocking interleukin 2 binding. However, use of anti-Tac as an immunosuppressant drug would be impaired by the human immune response against this murine antibody. We have therefore constructed a "humanized" antibody by combining the complementarity-determining regions (CDRs) of the anti-Tac antibody with human framework and constant regions. The human framework regions were chosen to maximize homology with the anti-Tac antibody sequence. In addition, a computer model of murine anti-Tac was used to identify several amino acids which, while outside the CDRs, are likely to interact with the CDRs or antigen. These mouse amino acids were also retained in the humanized antibody. The humanized anti-Tac antibody has an affinity for p55 of 3 x 10(9) M-1, about 1/3 that of murine anti-Tac.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
A simple and very efficient method for generating cDNA libraries
Gubler, U., & Hoffman, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90230-5 · Cited by 4,510
Reshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Uchiyama, T., Broder, S., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1393 · Cited by 1,329
Self-citationChimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
Morrison, S. L., Johnson, M. J., Herzenberg, L. A., & Oi, V. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6851 · Cited by 1,039
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., & Greene, W. C. (1982) · Nature · doi:10.1038/300267a0 · Cited by 864
Self-citationREMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
Hale, G., Clark, M. R., Marcus, R., Winter, G., Dyer, M. J. S., Phillips, J. M., Riechmann, L., & Waldmann, H. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90588-0 · Cited by 688
Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity Conditions
Sharon, M., Klausner, R. D., Cullen, B. R., Chizzonite, R., & Leonard, W. J. (1986) · Science · doi:10.1126/science.3095922 · Cited by 572
Production of functional chimaeric mouse/human antibody
Boulianne, G. L., Hozumi, N., & Shulman, M. J. (1984) · Nature · doi:10.1038/312643a0 · Cited by 550
Tsudo, M., Kozak, R. W., Goldman, C. K., & Waldmann, T. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9694 · Cited by 463
Self-citationSugden, B., Marsh, K., & Yates, J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.2.410 · Cited by 440
Hieter, P. A., Max, E. E., Seidman, J. G., Maizel, J. V., & Leder, P. (1980) · Cell · doi:10.1016/0092-8674(80)90168-3 · Cited by 393
Molecular dynamics of native protein
Levitt, M. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80304-0 · Cited by 356
Self-citationReshaping Human Antibodies: Grafting an Antilysozyme Activity
Verhoeyen, M., Milstein, C., & Winter, G. (1988) · Science · doi:10.1126/science.2451287 · Cited by 345
THE MULTI-SUBUNIT INTERLEUKIN-2 RECEPTOR
Waldmann, T. A. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.004303 · Cited by 329
Self-citationA hapten-specific chimaeric IgE antibody with human physiological effector function
Neuberger, M. S., Williams, G. T., Mitchell, E. B., Jouhal, S. S., Flanagan, J. G., & Rabbitts, T. H. (1985) · Nature · doi:10.1038/314268a0 · Cited by 289
Depper, J. M., Leonard, W. J., Robb, R. J., Waldmann, T. A., & Greene, W. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.690 · Cited by 246
Self-citationKirkman, R. L., Barrett, L. V., Gaulton, G. N., Kelley, V. E., Ythier, A., & Strom, T. B. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.1.358 · Cited by 189
ANTI-IDIOTYPIC AND NON-ANTI-INDIOTYPIC ANTIBODIES TO OKT3 ARISING DESPITE INTENSE IMMUNOSUPPRESSION
Jaffers, G. J., Fuller, T. C., Cosimi, A. B., Russell, P. S., Winn, H. J., & Colvin, R. B. (1986) · Transplantation · doi:10.1097/00007890-198605000-00004 · Cited by 185
Waldmann, T., Goldman, C., Bongiovanni, K., Sharrow, S., Davey, M., Cease, K., Greenberg, S., & Longo, D. (1988) · Blood · doi:10.1182/blood.v72.5.1805.1805 · Cited by 169
Self-citationThe nucleotide sequence of a human immnnoglobulin Cγlgene
Ellison, J. W., Berson, B. J., & Hood, L. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.13.4071 · Cited by 158
Expression in COS cells of a mouse—human chimaeric B72.3 antibody
Whittle, N., Adair, J. R., Lloyd, C., Jenkins, L., Devine, J. M., Schlom, J., Raubitschek, A. A., Colcher, D. M., & Bodmer, M. (1987) · Protein Engineering Design and Selection · doi:10.1093/protein/1.6.499 · Cited by 100
Synergism between immunoglobulin enhancers and promoters
Garcia, J. V., Bich‐Thuy, L. T., Stafford, J., & Queen, G. M. (1986) · Nature · doi:10.1038/322383a0 · Cited by 99
Reed, M. H., SHAPIRO, M. E., Strom, T. B., et al. (1989) · Transplantation · doi:10.1097/00007890-198901000-00013 · Cited by 64
Volk, H., Brocke, S., Osawa, H., & Diamantstein, T. (1986) · PubMed · Cited by 13
Cited by
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Winter, G., & Milstein, C. (1991) · Nature · doi:10.1038/349293a0 · Cited by 945
Anatomy of the antibody molecule
Padlan, E. A. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90001-9 · Cited by 896
Metadata
- Authors
- Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., & Waldmann, T. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1989-12
- Volume
- 86
- Issue
- 24
- Pages
- 10029-10033
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2052150715
- Cited by
- 627
- References
- 28
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.